Skip to main content

Animations

MJFF Publications

2821 - 2830 of 8715 Results
Title
Year
  • Year
  • 2011
  • 2012
  • 2015
  • 2012
  • 2012
  • 2006
  • 2014
  • 2014
  • 2018
  • 2007
  • Summary Details
    OPEN
    Title: Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar Degeneration
    Journal Name: Archives of Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/archneurol.2011.53
    Citation Count: 115
  • Summary Details
    OPEN
    Title: Reduced Uptake of FDOPA PET in End-stage Liver Disease With Elevated Manganese Levels
    Journal Name: Archives of Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/archneurol.2011.771
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-015-0038-3
    Citation Count: 110
  • Summary Details
    OPEN
    Title: Testing NF-κB-based Therapy in Hemiparkinsonian Monkeys
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-012-9377-9
    Citation Count: 40
  • Summary Details
    OPEN
    Title: RGS10 exerts a neuroprotective role through the PKA/c‐AMP response‐element (CREB) pathway in dopaminergic neuron‐like cells
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/j.1471-4159.2012.07780.x
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study.
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/1742-2094-3-29
    Citation Count: 138
  • Summary Details
    OPEN
    Title: Transgenic mice expressing S129 phosphorylation mutations in α-synuclein
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2014.01.033
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Leucine-Rich Repeat Kinase 2 Binds to Neuronal Vesicles through Protein Interactions Mediated by Its C-Terminal WD40 Domain
    Journal Name: Molecular and Cellular Biology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1128/mcb.00914-13
    Citation Count: 99
  • Summary Details
    OPEN
    Title: Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1713849115
    Citation Count: 197
  • Summary Details
    OPEN
    Title: Epidemiology of Parkinson's disease
    Journal Name: Handbook of Clinical Neurology
    Publisher: Elsevier
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s0072-9752(07)83006-5
    Citation Count: 131
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.